Dan Housman and Omer Saka of Roland Berger discuss how digital strategies for Target Product Profiling can create value and competitive advantage for life science organizations.
All content for Graticule Podcast Series is the property of Graticule, Inc. and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dan Housman and Omer Saka of Roland Berger discuss how digital strategies for Target Product Profiling can create value and competitive advantage for life science organizations.
RWD: Next Generation of Establishing Therapeutic Value
Graticule Podcast Series
43 minutes 45 seconds
5 years ago
RWD: Next Generation of Establishing Therapeutic Value
Advanced real-world data including clinical notes, imaging, consumer data, and remote monitoring are redefining therapeutic value in modern reimbursement and prescribing dialogs. In the latest episode of Graticule’s Novel Cohorts Podcast Ömer Saka, Real-World Evidence Leader at PwC Switzerland and Dan Housman, CTO & Co- founder at Graticule, Inc. explore the emergence of a new generation of therapeutic value research.
Graticule Podcast Series
Dan Housman and Omer Saka of Roland Berger discuss how digital strategies for Target Product Profiling can create value and competitive advantage for life science organizations.
